ISSN: 0443-511
e-ISSN: 2448-5667
Usuario/a
Idioma
Herramientas del artículo
Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión)
Tamaño de fuente

Open Journal Systems

Factores de riesgo y de estilo de vida asociados a enfermedad renal crónica

Sandra Maricruz López-Heydeck, Julio Basilio Robles-Navarro, Laura Patricia Montenegro-Morales, José de Jesús Garduño-García, Jerónimo Amado López-Arriaga

Resumen


El estilo de vida tiene una influencia determinante en el avance de la enfermedad renal crónica (ERC), la cual inicia con algún daño renal que puede permanecer y progresar por la acción de factores de riesgo, además de que pueden agregarse lesiones renales a lo largo de la vida. Es más común en personas adultas y frecuentemente permanece oculta a los análisis habituales, pero si logra detectarse de manera temprana puede atenderse con el fin de aplicar estilos de vida saludables que permitan detener o alargar el avance del daño renal, para evitar o retardar la necesidad de diálisis o de trasplante. El objetivo de este trabajo es dar a conocer los posibles estilos de vida que se deben implementar, como las visitas al médico, no fumar, tener actividad de intensa a moderada, consumir suficientes vegetales y frutas, y evitar dietas altas en hidratos de carbono y lípidos. Para llevar a cabo la revisión se obtuvo literatura de bases de datos entre 1980 y 2017, de libre acceso, utilizando las palabras clave en inglés “chronic kidney disease (CKD)”, “lifestyle” y “risk factors”, y sus equivalentes en español.


Palabras clave


Enfermedad Renal Crónica; Factores de Riesgo; Estilo de Vida

Texto completo:

PDF HTML PubMed

Referencias


 

Lalonde M. El concepto de “campo de la salud“:una perspectiva canadiense. En:Organización Mundial de la Salud. Promoción de la salud:una antología. Publicación Científica N.º557. Washington DC:OMS;1996. 3-5.

 

Vargas-Oreamuno S. Los estilos de vida en la salud. Análisis de los determinantes de la salud en Costa Rica. En:La salud pública en Costa Rica. Costa Rica:Universidad de Costa Rica;2011.

 

World Health Organization. The World Health Report 2002. Reducing Risks, Promoting Healthy Life. Switzerland:WHO;2002.

 

World Health Organization. Lifestyles and living conditions and their impact on health, ICP/HED. Geneva:WHO;1982.

 

World Kidney Day. Press release. WKD;2011. Disponible en:https://www.worldkidneyday.org/resources/press-materials/

 

García-García G, Monteon-Ramos JF, García-Bejarano H, Gómez-Navarro B, Hernández-Reyes I, LomelíAM, et al. Renal replacement therapy among disadvantaged populations in Mexico:a report from the Jalisco Dialysis and Transplant Registry (REDTJAL). Kidney Int. 2005;68:S58-61. doi:10.1111/j.1523-1755.2005.09710.x

 

Amato D, Álvarez-Aguilar C, Castañeda-Limones R, Rodríguez E, Ávila-Díaz M, Arreola F, et al. Prevalence of chronic kidney disease in an urban Mexican population. Kidney Int. 2005;68:S11-7.

 

United States Renal Data System. International Comparisons. Minneapolis, MN:USRDS;2018. Disponible en:https://www.usrds.org/media/1738/v2_c11_intcomp_18_usrds.pdf

 

Alcázar R, Egocheaga MI, Orte L, Lobos M, González-Parra E, Álvarez-Guisasola F, et al. Documento de consenso SEN-semFYC sobre la enfermedad renal crónica. Nefrología. 2008;28(3):273-82.

 

Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison's Principles of internal medicine. 17th ed. New York:McGraw Hill;2008.

 

KDOQI Clinical Practice Guidelines for Chronic Kidney Disease:Evaluation, Classification and Stratification. KDOQI Guidelines for CKD Care. The National Kidney Foundation Kidney Disease Outcomes Quality Initiative, KDOQI;2002.

 

Gómez-Navarro R. Prevalencia de la enfermedad renal crónica determinada mediante la aplicación de ecuaciones predictivas en personas hipertensas atendidas en atención primaria. Rev Esp Salud Publica. 2009;83(3):463-9.

 

Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, et al. Prevalence of kidney damage in Australian adults:the AusDiab Kidney Study. J Am Soc Nephrol. 2003;14:S131-8.

 

Summary of Recommendation Statements. Kidney Int Suppl (2011). 2013;3(1):5-14.

 

Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, et al. The definition, classification and prognosis of chronic kidney disease:a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17-28.

 

National Kidney Foundation. Frequently asked questions about GFR estimates (GFRe). New York, NY:National Kidney Foundation;2014. Disponible en:https://www.kidney.org/sites/default/files/docs/12-10-4004_abe_faqs_aboutgfrrev1b_singleb.pdf

 

Chotayaporn T, Kasitanon N, Sukitawut W, Louthrenoo W. Comparison of proteinuria determination by urine dipstick, spot urine protein creatinine index, and urine protein 24 hours in lupus patients. J Clin Rheumatol. 2011;17(3):124-9.

 

Teng HL, Yen M, Fetzer S, Sung J-M, Hung S-Y. Effects of targeted interventions on lifestyle modifications of chronic kidney disease patients:randomized controlled trial. West J Nurs Res. 2013;20(10):1-21.

 

Ruiz-Mejía R, Ortega-Olivares LM, Suárez-Otero R. Metas de control de la presión arterial en pacientes con enfermedad renal crónica sin tratamiento dialítico. Med Int Mex. 2014;30(6):675-86.

 

Stengel B, Tarver-Carr ME, Powe NR, Eberhardt MS, Brancati FL. Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology. 2003;14(4):479-87.

 

Méndez-Durán A, Méndez-Bueno JF, Tapia-Yáñez T, Muñoz Montes A, Aguilar-Sánchez L. Epidemiología de la insuficiencia renal crónica en México. Dial Traspl. 2010;31(1):7-11.

 

JNC 7 express. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung and Blood Institute;2003. 2-3.

 

Arulkumaran N, Diwakar R, Tahir Z, Mohamed M, Kaski JC, Banerjee D. Pulse pressure and progression of chronic kidney disease. J Nephrol. 2010;23(2):189-93.

 

Briet M, Boutouyrie P, Laurent S, London GM. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82:388-400. doi:10.1038/ki.2012.131

 

Chen J, Muntner P, Hamm LL, Fonseca V, Batuman V, Whelton PK, et al. Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. J Am Soc Nephrol. 2003;14:469-77.

 

Tsimihodimos V, Dounousi E, Siamopoulos KC. Dyslipidemia in chronic kidney disease:an approach to pathogenesis and treatment.Am J Nephrol. 2008;28:958-73. doi:10.1159/000144024

 

Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol. 2008;19:593-9. doi:10.1681/ASN.2007030355

 

Lankin VZ, Lisina MO, Arzamastseva NE, Konovalova GG, Nedosugova LV, Kaminnyi AI, et al. Oxidative stress in atherosclerosis and diabetes. Bull Exp Biol Med. 2005;140(1):41-3.

 

Alegría-Martínez P, Alegría-Grijelmo P. Envejecimiento celular y procesos asociados:estrés oxidativo y enfermedad. DermaThea Innovación;2006.

 

Bharakhada N, Yates T, Davies MJ, Wilmot EG, Edwardson C, Henson J, et al. Association of sitting time and physical activity with CKD:a cross-sectional study in family practices. Am J Kidney Dis. 2012;60(4):583-90. doi:10.1053/j.ajkd.2012.04.024

 

Kesaniemi YA, Danforth E Jr, Jensen MD, Kopelman PG, Lefebvre P, Reeder BA, et al. Dose-response issues concerning physical activity and health:an evidence-based symposium. Med Sci Sport Exerc. 2001;33(6 Suppl):S531-8.

 

Haskell WL, Lee I-M, Pate RR. Physical activity and public health. Updated Recommendation for Adults from the American College of Sports Medicine and the American Heart Association (ACSM/AHA). Circulation. 2007;116:1081-93. doi:10.1161/CIRCULATIONAHA.107.185649

 

K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease. AJKD. 2003;42(4;3):S12-28.

 

Cunningham J, Rodríguez M, Messa P. Magnesium in chronic kidney disease stages 3 and 4 and in dialysis patients. Clin Kidney J. 2012;5(Suppl 1):139-51.

 

Evenpoel P, Myles W. A balanced view of calcium and phosphate homeostasis in chronic kidney disease. Kidney Int. 2013;83(5):789-91.

 

Negri AL. The klotho gene:a gene predominantly expressed in the kidney is a fundamental regulator of aging and calcium/phosphorus metabolism. J Nephrol. 2005;18(6):654-8.

 

Mitobe M, Yoshida T, Sugiura H, Shirota S, Tsuchiya K, Nihei H. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol. 2005;101:e67-74.

 

Leonberg-Yoo AK, Sarnak MJ. Don't pass the salt:evidence to support avoidance of high salt intake in CKD. Am J Kidney Dis. 2017;69(2):175-8. doi:https://doi.org/10.1053/j.ajkd.2016.09.008

 

Weir MR, Fink JC. Salt intake and progression of chronic kidney disease:an overlooked modifiable exposure?A commentary. Am J Kidney Dis. 2005;45(1):176-88. doi:https://doi.org/10.1053/j.ajkd.2004.08.041

 

Clark WF, Huang S-H, Garg AX, Gallo K, House AA, Moist L,et al. The Chronic Kidney Disease Water Intake Trial:protocol of a randomized controlled trial. Can J Kidney Health Dis. 2017;4:2054358117725106. doi:10.1177/2054358117725106

 

Nakagawa T, Kang D-H, Feig D, Sanchez-Lozada LG, Srinivas TR, Sautin Y, et al. Unearthing uric acid:an ancient factor with recently found significance in renal and cardiovascular diseases. Kidney Int. 2006;69:172-25.

 

Ryoo J-H, Choi J-M, Oh Ch-M, Kim M-G. The association between uric acid and chronic kidney disease in Korean men:a 4-year follow-up study. Korean Med Sci. 2013;28:855-60.

 

Khosla U, Zharikov S, Finch J, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005;67:1739-42.

 

Hayden MR, Tyagi SC. Uric acid:a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus:the urate redox shuttle. Nutr Metab. 2004;1:1-10.

 

Drechsler C, Kollerits B, Meinitzer A, März W, Ritz E, König P, et al.;for the MMKD Study Group. Homoarginine and progression of chronic kidney disease:results from the Mild to Moderate Kidney Disease Study. PLoS One. 2013;8(5):e63560.

 

Cao G, Booth SL, Sadowski JA, Prior RL. Increase in human plasma antioxidant capacity after consumption of controlled diets high in fruits and vegetables. Am J Clin Nutr. 1998;68:1081-7.

 

Genkinger JM, Platz EA, Hoffman SC, Comstock GM, Helzlsouer KJ. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol. 2004;160(12):1223-33. doi:10.1093/aje/kwh339

 

Singh U, Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev. 2008;66(11):646-57.

 

Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, et al. Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus:a placebo-controlled pilot trial. Radic Biol Med. 1999;27(3-4):309-14.

 

Kamenova P. Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens). 2006;5(4):251-8.

 

Noori N, Tabibi H, Hosseinpanah F, Hedayati M, Nafar M. Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropaty. Int J Vitamin Nutr Res. 2013;83(2):77-85. doi:10.1024/0300-9831/a000147

 

Udupa AS, Nahar PS, Shah SH, Kshirsagar MJ, Ghongane BB. Study of comparative effects of antioxidants on insulin sensitivity in type 2 diabetes mellitus. J Clin Diagn Res. 2012;6(9):1469-73. doi:10.7860/JCDR/2012/4464.2535

 

Udupa A, Nahar P, Shah S, Kshirsagar M, Ghongane B. A comparative study of effects of omega-3 fatty acids, alpha lipoic acid and vitamin E in type 2 diabetes mellitus. Ann Med Health Sci Res. 2013;3(3):442-6.

 

Virtanen JK, Mozaffarian D, Chiuve SE, Rimm EB. Fish consumption and risk of major chronic disease in men. Am J Clin Nutr. 2008;88(6):1618-25. doi:10.3945/ajcn.2007.25816

 

Appel LJ, Sacks FM, Carey VJ, Obarzanek E, Swain JF, Miller ER 3rd, et al.;OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids:results of the OmniHeart randomized trial. JAMA. 2005;294(19):2455-64. doi:10.1001/jama.294.19.2455

 

Halton TL, Willett WC, Liu S, Manson JE, Albert CM, Rexrode K, et al. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006;355(19):1991-2002. doi:10.1056/NEJMoa055317

 

Jenkins DJ, Wong JM, Kendall CW, Esfahani A, Ng VW, Leong TC, et al. The effect of a plant-based low-carbohydrate (“Eco-Atkins“) diet on body weight and blood lipid concentrations in hyperlipidemic subjects. Arch Intern Med. 2009;169(11):1046-54. Erratum in:Arch Intern Med. 2009;169(16):1490.

 

Bilsborough S, Mann N. A review of issues of dietary protein intake in humans. Int J Sport Nutr Exerc Metab. 2006;16(2):129-52.

 

Institute of Medicine. Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein, and amino acids. Washington, DC:The National Academies Press;2005. https://doi.org/10.17226/10490

 

National Kidney Foundation. Chronic Kidney Disease 2006:A Guide to Select NKF-KDOQI Guidelines and Recommendations. New York, NY:National Kidney Foundation;2006. Disponible en:https://www.kidney.org/sites/default/files/docs/pharmacist_cpg.pdf

 

Fouque D, Laville M. Low protein diets for chronic kidney disease in non diabetic adults. Cochrane Database Syst Rev. 2009;(3):CD001892. doi:10.1002/14651858.CD001892.pub3

 

Noce A, Vidiri MF, Marrone G, Moriconi E, Bocedi A, Capria A, et al. Is low-protein diet a possible risk factor of malnutrition in chronic kidney disease patients?Cell Death Discovery. 2016;2:16026. doi:10.1038/cddiscovery.2016.26

 

Perneger TV, Whelton PK, Puddey IB, Clag MJ. Risk of end-stage renal disease associated with alcohol consumption. Am J Epidemiol. 1999;150(12):1275-81. doi:10.1093/oxfordjournals.aje.a009958

 

Renaud S, Lorgeril M. Wine alcohol, platelets and the French paradox for coronary heart disease. Lancet. 1992;339(8808):1523-6. doi:10.1016/0140-6736(92)91277-f

 

Lima MG, Francisco PMSB, Barros M. Sleep duration pattern and chronic disease in Brazilian adults (ISACAMP 2008/2009). Sleep Med. 2012;13:139-44.

 

Dunkler D, Kohl M, Teo KK, Heinze G, Dehghan M, Clase CM, et al.;ONTARGET investigators. Population-attributable fractions of modifiable lifestyle factors for CKD and mortality in individuals with type 2 diabetes:a cohort study. Am J Kidney Dis. 2016;68(1):29-40.

 

Marshall SJ, Biddle SH. The transtheoretical model of behavior change:a meta-analysis of applications to physical activity and exercise. Ann Behav Med. 2001;23:229-43.

 

Evangelidis N, Craig J, Bauman A, Manera K, Saglimbene V, Tong A. Lifestyle behavior change for preventing the progression of chronic kidney disease:a systematic review. BMJ Open. 2019;9:e031625. doi:10.1136/bmjopen-2019-031625

 

Berdal G, BøI, Dager TN, Dingsør A, Eppeland SG, Hagfors J, et al. Structured goal planning and supportive telephone follow up in rheumatology care:results from a pragmatic stepped-wedge cluster-randomized trial. Arthritis Care Res (Hoboken). 2018;70(11):1576-86.

 

Dombrowski SU, Sniehotta FF, Avenell A, Johnston M, McLennan G, Araujo-Soares V, et al. Identifying active ingredients in complex behavioural interventions for obese adults with obesity-related co-morbidities or additional risk factors for comorbidities:a systematic review. Health Psychol Rev 2012;6:7-32.

 

Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions:a meta-regression. Health Psychol. 2009;28:690-701.

 

Morony S, Flynn M, McCaffery KJ, Jansen J, Webster AC. Readability of written materials for CKD patients:a systematic review. Am J Kidney Dis. 2015;65:842-50.

 

Taylor DM, Fraser SDS, Bradley JA, Bradley C, Draper H, Metcalfe W, et al. A systematic review of the prevalence and associations of limited health literacy in CKD. Clin J Am Soc Nephrol. 2017;12:1070-84.

 

World Health Organization. Behaviour change strategies and health:the role of health systems. Paper presented at Regional Committee for Europe. Tbilisi, Georgia:WHO;15-18 September 2008.

 

National Institute for Health and Care Excellence. Behaviour change:individual approaches. NICE guidelines [PH49];2014. Disponible en:https://www.nice.org.uk/guidance/ph49

 

Lopez-Vargas PA, Tong A, Howell M, Phoon RK, Chadban SJ, Shen Y, et al. Patient awareness and beliefs about the risk factors and comorbidities associated with chronic kidney disease:a mixed-methods study. Nephrology (Carlton). 2017;22:374-81.

 

Palmer SC, Maggo JK, Campbell KL, Craig JC, Johnson DW, Sutanto B, et al. Dietary interventions for adults with chronic kidney disease. Cochrane Database Syst Rev. 2017;(4):CD011998. doi:10.1002/14651858.CD011998.pub2




DOI: https://doi.org/10.24875/RMIMSS.M20000035

Enlaces refback

  • No hay ningún enlace refback.